
1,4-Dibromopentane | CAS:626-87-9
1,4-Dibromopentane
- 名称:1,4-二溴戊烷 | 1,4-Dibromopentane
- CAS号:626-87-9
- 别名:
- 分子式:C5H10Br2
- 分子量:229.94
- EINESC号:210-967-2
产品描述
物理化学性质
熔点 | -34.4 ºC |
---|---|
沸点 | 102-103 ºC (15 mmHg) |
闪点 | 110 ºC |
密度 | 1.687 |
折射率 | 1.537-1.547 |
安全数据
危险品标志 | Xn |
---|---|
危险类别码 | R22;R36/38 |
安全说明书 | S26;S37/39 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Synthesis of base-modified noraristeromycin derivatives and their inhibitory activity against human and Plasmodium falciparum recombinant S-adenosyl-L-homocysteine hydrolaseKitade Y, et al. Tetrahedron, 58(7), 1271-1277 (2002)
Myers, A.G. et al. Tetrahedron Letters, 37, 3083-3083 (1996)
Variable and stereoselective synthesis of azasugar analogues by a ruthenium-catalyzed ring rearrangementVoigtmann U and Blechert S Organic Letters, 2(25), 3971-3974 (2000)
Theil, F. et al. Journal of the Chemical Society. Perkin Transactions 1, 255-255 (1996)
An improved preparation of highly enantiomerically enriched (R)-(+)-4-tert-butyldimethylsiloxy-2-cyclopenten-1-oneMyers AG, et al. Tetrahedron Letters, 37(18), 3083-3086 (1996)
(4R)-(+)-tert-Butyldimethylsiloxy-2-Cyclopenten-1-one: 2-Cyclopenten-1-one, 4-[[(1, 1-dimethylethyl) dimethylsilyl] oxy]-,(R)-Paquette LA, Organic Syntheses, 73(18), 36-36 (1996)
Facile synthesis of 9-[(1′ R, 2′ S)-2′-hydroxy-3′-oxocyclopentan-1′-yl]-9-H-adenine possessing inhibitory activity against human recombinant S-adenosyl-l-homocysteine hydrolaseKitade Y, et al. Tetrahedron Letters, 42(3), 433-435 (2001)
Design, synthesis, and anti-HIV activity of 4′-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitorsBoojamra CG, et al. Bioorganic & Medicinal Chemistry, 17(4), 1739-1746 (2009)
Chemoenzymatic synthesis of carbocyclic nucleoside analogues with bicyclo [3.1. 0] hexyl residuesTheil F, et al. Journal of the Chemical Society. Perkin Transactions 1, 255-258 (1996)
Paquette, L.A. et al. Organic Syntheses, 73, 36-36 (1995)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!